Uncovering the mechanisms behind T cell differentiation
The research team investigated the regulatory mechanisms that guide the optimal differentiation of ... which regulators help ...
GlobalData on MSN5d
Medigene and EpimAb to develop T cell engagers for solid tumours
Medigene and EpimAb Biotherapeutics have signed a co-development agreement involving T cell receptor (TCR)-guided T cell ...
techexplorist5d
Researchers identified one of the levers that controls the fate of T cells
Naïve CD8 T cells can change into different types of effector and memory CD8 T cells when the immune system responds to ...
News Medical on MSN11d
Development of lymphoma following CAR-T cell therapy
Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes. In recent years, CAR-T cell therapies have become ...
Medigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell Engagers
EpimAb_LogoPlanegg/Martinsried and Shanghai, February 27, 2025. Medigene AG (Medigene, FSE: MDG1, Prime Standard) and EpimAb Biotherapeutics, ...
Nature7d
Cellular immunity articles from across Nature Portfolio
which in turn promotes Th2 cell differentiation while suppressing the Tfh cell fate decision. The naïve CD4 T cell compartment is traditionally deemed as homogenous. Here, by leveraging scRNA-seq ...
Pharmabiz5d
Medigene & EpimAb ink co-development partnership for TCR-guided T Cell Engagers to treat of immune-related disorders
Planegg, Martinsried Saturday, March 1, 2025, 11:00 Hrs [IST] ...
technologynetworks1mon
T Cells’ Ability To Prevent Infections Opens New Avenues for Developing Vaccines
Historically, vaccine development has prioritised generating elevated levels of antibodies. This approach may not only limit the efficacy of vaccines but could also hinder our ability to combat ...